Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022310
Company: ASTRAZENECA
Company: ASTRAZENECA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CASODEX | BICALUTAMIDE | 50MG | TABLET; ORAL | Prescription | TBD | TBD | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
12/19/2008 | ORIG-1 | Approval | Type 6 - New Indication (no longer used) | PRIORITY |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022310lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022310s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022310_casodex_toc.cfm |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
12/19/2008 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022310lbl.pdf |
CASODEX
There are no Therapeutic Equivalents.